Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Colombo

Showing results (361-370 of 372) with videos related to

Pageof 38
Sort By:
The Lancet. Infectious Diseases|February 25, 2016
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trialMichael Manns, Didier Samuel, Edward J Gane, et al.
Journal of Hepatology|August 22, 2008
Statements from the Taormina expert meeting on occult hepatitis B virus infectionGiovanni Raimondo, Jean-Pierre Allain, Maurizia R Brunetto, et al.
Journal of Hepatology|April 18, 2016
Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinomaGhassan K Abou-Alfa, Oscar Puig, Bruno Daniele, et al.
Journal of Hepatology|October 27, 2016
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradicationAdriaan J van der Meer, Jordan J Feld, Harald Hofer, et al.
Journal of Hepatology|June 11, 2018
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030Chris Estes, Quentin M Anstee, Maria Teresa Arias-Loste, et al.
Nature Communications|August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infectionAtish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.
Cancer Management and Research|January 7, 2022
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in ItalyValentina Burgio, Massimo Iavarone, Giovanni Giuseppe Di Costanzo, et al.
Hepatology Communications|November 23, 2021
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort StudyLuca Valenti, Serena Pelusi, Alessio Aghemo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 5, 2022
Securing wider EU commitment to the elimination of hepatitis C virusHeiner Wedemeyer, Tammo L Tergast, Jeffrey V Lazarus, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 23, 2016
Management of biliary anastomotic strictures after liver transplantation (BASALT study): A nationwide Italian surveyPaolo Cantù, Ilaria Parzanese, Valerio Balassone, et al.
Pageof 38

Showing results (361-370 of 372) with videos related to

Sort By:
Pageof 38
The Lancet. Infectious Diseases|February 25, 2016
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trialMichael Manns, Didier Samuel, Edward J Gane, et al.
Journal of Hepatology|August 22, 2008
Statements from the Taormina expert meeting on occult hepatitis B virus infectionGiovanni Raimondo, Jean-Pierre Allain, Maurizia R Brunetto, et al.
Journal of Hepatology|April 18, 2016
Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinomaGhassan K Abou-Alfa, Oscar Puig, Bruno Daniele, et al.
Journal of Hepatology|October 27, 2016
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradicationAdriaan J van der Meer, Jordan J Feld, Harald Hofer, et al.
Journal of Hepatology|June 11, 2018
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030Chris Estes, Quentin M Anstee, Maria Teresa Arias-Loste, et al.
Nature Communications|August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infectionAtish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.
Cancer Management and Research|January 7, 2022
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in ItalyValentina Burgio, Massimo Iavarone, Giovanni Giuseppe Di Costanzo, et al.
Hepatology Communications|November 23, 2021
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort StudyLuca Valenti, Serena Pelusi, Alessio Aghemo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 5, 2022
Securing wider EU commitment to the elimination of hepatitis C virusHeiner Wedemeyer, Tammo L Tergast, Jeffrey V Lazarus, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 23, 2016
Management of biliary anastomotic strictures after liver transplantation (BASALT study): A nationwide Italian surveyPaolo Cantù, Ilaria Parzanese, Valerio Balassone, et al.
Pageof 38